Diet and exercise interventions among overweight and obese lactating women: randomized trial of effects on cardiovascular risk factors
- PMID: 24516621
- PMCID: PMC3917884
- DOI: 10.1371/journal.pone.0088250
Diet and exercise interventions among overweight and obese lactating women: randomized trial of effects on cardiovascular risk factors
Abstract
Objective: To examine the effects of Diet (D) and Exercise (E) interventions on cardiovascular fitness, waist circumference, blood lipids, glucose metabolism, inflammation markers, insulin-like growth factor 1 (IGF-1) and blood pressure in overweight and obese lactating women.
Methods: At 10-14 wk postpartum, 68 Swedish women with a self-reported pre-pregnancy BMI of 25-35 kg/m(2) were randomized to a 12-wk behavior modification treatment with D, E, both or control using a 2×2 factorial design. The goal of D treatment was to reduce body weight by 0.5 kg/wk, accomplished by decreasing energy intake by 500 kcal/d and monitoring weight loss through self-weighing. The goal of E treatment was to perform 4 45-min walks per wk at 60-70% of max heart-rate using a heart-rate monitor. Effects were measured 12 wk and 1 y after randomization. General Linear Modeling was used to study main and interaction effects adjusted for baseline values of dependent variable.
Results: There was a significant main effect of the D treatment, decreasing waist circumference (P = 0.001), total cholesterol (P = 0.007), LDL-cholesterol (P = 0.003) and fasting insulin (P = 0.042), at the end of the 12-wk treatment. The decreased waist circumference (P<0.001) and insulin (P = 0.024) was sustained and HDL-cholesterol increased (P = 0.005) at the 1-y follow-up. No effects from the E treatment or any interaction effects were observed.
Conclusions: Dietary behavior modification that produced sustained weight loss among overweight and obese lactating women also improved risk factors for cardiovascular disease and type 2 diabetes. This intervention may not only reduce weight-related risks with future pregnancies but also long-term risk for metabolic disease.
Trial registration: ClinicalTrials.gov NCT01343238.
Conflict of interest statement
Figures
References
-
- Norberg M, Danielsson M (2012) Overweight, cardiovascular diseases and diabetes : Health in Sweden: The National Public Health Report 2012 Chapter 7. Scand J Public Health 40: 135–163. - PubMed
-
- Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, et al. (2010) Heart disease and stroke statistics–2010 update: a report from the American Heart Association. Circulation 121: e46–e215. - PubMed
-
- Schenck-Gustafsson K (2009) Risk factors for cardiovascular disease in women. Maturitas 63: 186–190. - PubMed
-
- Lawlor DA, Emberson JR, Ebrahim S, Whincup PH, Wannamethee SG, et al. (2003) Is the association between parity and coronary heart disease due to biological effects of pregnancy or adverse lifestyle risk factors associated with child-rearing? Findings from the British Women’s Heart and Health Study and the British Regional Heart Study. Circulation 107: 1260–1264. - PubMed
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
